Clin Case Rep 2020
DOI: 10.37421/jccr.2020.10.1368
|View full text |Cite
|
Sign up to set email alerts
|

Angiotensin Converting Enzyme (ACE) Inhibitor-Induced Cough Resulting in Prescribing Cascade

Abstract: Objective: Prescribing cascade usually results from the misdiagnosis of a drug-related adverse event or condition. Although the prevalence of prescribing cascade remains unknown, it likely increases the risks associated with polypharmacy (e.g., adverse drug events). Furthermore, consequences of prescribing cascade are more likely to be detrimental for the elderly population due to the presence of multiple chronic diseases and the complexity of the derived medication regimen. This case aims to shed light on a p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…This case illustrates several occurrences of drug-induced phenoconversion, resulting in a prescribing cascade of multiple antidepressants and an opioid, and in an overall high sedative burden, which led to a fall-related injury. This prescribing cascade may have been influenced by pharmacotherapy failure due to drug–gene (DGIs) and drug–drug–gene interactions (DDGIs), contrasting the more commonly described prescribing cascade that results from misdiagnosis or treating an adverse drug event as a new condition [ 7 , 8 ]. Following the fall, the PGx clinical service was consulted, and PGx testing was performed.…”
Section: Introductionmentioning
confidence: 99%
“…This case illustrates several occurrences of drug-induced phenoconversion, resulting in a prescribing cascade of multiple antidepressants and an opioid, and in an overall high sedative burden, which led to a fall-related injury. This prescribing cascade may have been influenced by pharmacotherapy failure due to drug–gene (DGIs) and drug–drug–gene interactions (DDGIs), contrasting the more commonly described prescribing cascade that results from misdiagnosis or treating an adverse drug event as a new condition [ 7 , 8 ]. Following the fall, the PGx clinical service was consulted, and PGx testing was performed.…”
Section: Introductionmentioning
confidence: 99%